ChemicalBook >> CAS DataBase List >>Enalapril maleate

Enalapril maleate

CAS No.
76095-16-4
Chemical Name:
Enalapril maleate
Synonyms
Olivin;Renitek;Renivace;Enalapril Maleate Salt;(S)-1-((S)-2-((S)-1-ETHOXY-1-OXO-4-PHENYLBUTAN-2-YLAMINO)PROPANOYL)PYRROLIDINE-2-CARBOXYLIC ACID MALEATE;BQL;Pres;Ednyt;Envas;Nuril
CBNumber:
CB1467853
Molecular Formula:
C24H32N2O9
Molecular Weight:
492.52
MDL Number:
MFCD00133304
MOL File:
76095-16-4.mol
MSDS File:
SDS
Last updated:2024-04-17 18:50:11

Enalapril maleate Properties

Melting point 143-144,5°C
Boiling point 0°C
alpha D25 -42.2° (c = 1 in methanol)
Flash point 0°C
storage temp. 2-8°C
solubility methanol: ≥50 mg/mL, clear, colorless to yellow
form powder
pka pKa1 3.0; pKa2 (25°) 5.4
color white to off-white
Water Solubility Soluble in water, methanol, and ethanol.
λmax 208nm(MeOH)(lit.)
Merck 14,3567
BCS Class 1 (LogP), 3 (CLogP)
InChIKey OYFJQPXVCSSHAI-QFPUQLAESA-N
CAS DataBase Reference 76095-16-4(CAS DataBase Reference)
NCI Dictionary of Cancer Terms PRES
FDA UNII 9O25354EPJ
NCI Drug Dictionary Enacard

Pharmacokinetic data

Protein binding 50-60%
Excreted unchanged in urine 20%
Volume of distribution 0.17(L/kg)
Biological half-life 11 / 34-60

SAFETY

Risk and Safety Statements

Symbol(GHS)  GHS hazard pictograms
GHS08
Signal word  Warning
Hazard statements  H361fd
Precautionary statements  P201-P202-P280-P308+P313-P405-P501
Hazard Codes  Xi,Xn
Risk Statements  36/37/38-62-63
Safety Statements  22-24/25-36/37-26
RIDADR  3077
WGK Germany  2
RTECS  TW3666000
HS Code  29339900
Toxicity LD50 oral in rat: 2973mg/kg
NFPA 704
0
3 0

Enalapril maleate price More Price(51)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Sigma-Aldrich BP741 Enalapril maleate British Pharmacopoeia (BP) Reference Standard 76095-16-4 100MG $229 2024-03-01 Buy
Sigma-Aldrich 1235300 Enalapril maleate United States Pharmacopeia (USP) Reference Standard 76095-16-4 200mg $436 2024-03-01 Buy
Sigma-Aldrich 16616 Enalapril maleate salt analytical standard 76095-16-4 50mg $71.7 2022-05-15 Buy
TCI Chemical E1010 Enalapril Maleate >98.0%(HPLC)(T) 76095-16-4 1g $51 2024-03-01 Buy
TCI Chemical E1010 Enalapril Maleate >98.0%(HPLC)(T) 76095-16-4 5g $197 2024-03-01 Buy
Product number Packaging Price Buy
BP741 100MG $229 Buy
1235300 200mg $436 Buy
16616 50mg $71.7 Buy
E1010 1g $51 Buy
E1010 5g $197 Buy

Enalapril maleate Chemical Properties,Uses,Production

Description

Enalapril maleate is the second angiotensin converting enzyme inhibitor to reach the marketplace. Like captopril, the first entry in this area, enalapril is useful in the treatment of hypertension and congestive heart failure. It has a longer effective half-life than captopril, allowing once or twice-daily dosing, and appears to have a somewhat lower incidence of side effects.

Chemical Properties

White to Off-White Crystalline Powder

Originator

Merck (USA)

Uses

sunscreen

Uses

Enalapril maleate salt is used as a long-acting ACE inhibitor and antihypertensive, used to study diabetic angiopathy in diabetic rats and inhibition of ACE in hog plasma (I50=1.2nM). ACE inhibitors disturb the enin-angiotensin- aldosterone system. Additional ACE inhibitors include: Enalapril, Enalaprilat dihydrate, Enalaprilat, and Enalapril-d5 Maleate Salt, among others.

Uses

An antihypertensive. An angiotensin-converting enzyme (ACE) inhibitor.

Definition

ChEBI: The maleic acid salt of enalapril. It contains one molecule of maleic acid for each molecule of enalapril. Following oral administration, the ethyl ester group of enalapril is hydrolysed to afford the corresponding carboxylic acid, enalaprilat, an angioten in-converting enzyme (ACE) inhibitor. Enalapril is thus a prodrug for enalaprilat (which, unlike enalapril, is not absorbed by mouth), and its maleate is used in the treatment of hypertension and heart failure, for reduction of proteinuria and renal diseas in patients with nephropathies, and for the prevention of stroke, myocardial infarction, and cardiac death in high-risk patients.

Manufacturing Process

N-[1(S)-Ethoxycarbonyl-3-phenylpropyl]-L-alanyl-L-proline maleic acid salt
A mixture of 3 g of L-alanyl-L-proline, 5 g of ethyl 2-oxo-4-phenyl-butanoate, 13 g of 3A molecular sieves, and 3.6 g of Raney nickel in 85 ml of ethanol is hydrogenated at 25°C and at 40 psig of hydrogen until uptake of hydrogen ceases. The solids are filtered, washed with 80 ml of ethanol and the filtrates are combined. Assay by high pressure liquid chromatography shows an 87:13 ratio of diastereoisomers in favor of the desired product. Ethanol is removed under vacuum to afford an oil which is dissolved in 60 ml of water and 20 ml of ethyl acetate. The pH of the stirred two-phase mixture is adjusted to 8.6 with 50% NaOH. The layers are separated and the water phase is extracted with 2x20 ml of ethyl acetate. The water phase is adjusted to pH 4.25 with hydrochloric acid, 12 g of NaCl is dissolved in the water, and product is extracted with 5x12 ml of ethyl acetate. The extracts are combined and dried with Na2SO4. The desired product, N-[1-(S)-ethoxycarbonyl-3-phenylpropyl]- L-alanyl-L-proline, is crystallized as its maleate salt by addition of 1.86 g of maleic acid. After stirring for 4 hours, the salt is filtered, washed with ethyl acetate and dried to afford 5.2 g of pure product, melting point 150°-151°C.

brand name

RENITEN

Therapeutic Function

Antihypertensive

General Description

Enalapril maleate, 1-[N[(S)-1-carboxy-3-phenylpropyl]-L-alanyl]-L-proline 1 -ethyl estermaleate (Vasotec), is a long-acting ACE inhibitor. It requiresactivation by hydrolysis of its ethyl ester to form thediacid enalaprilat. Enalapril is devoid of the side effects ofrash and loss of taste seen with captopril. These side effectsare similar to those of the mercapto-containing drugpenicillamine. The absence of the thiol group in enalaprilmaleate may free it from these side effects. The half-life is11 hours.

Biochem/physiol Actions

A long-acting angiotensin-converting enzyme inhibitor.

Clinical Use

Angiotensin converting enzyme inhibitor:
Hypertension
Heart failure

Veterinary Drugs and Treatments

The principle use of enalapril/enalaprilat in veterinary medicine at present is as a vasodilator in the treatment of heart failure. Recent studies have demonstrated that enalapril, particularly when used in conjunction with furosemide, does improve the quality of life in dogs with heart failure. It is not clear, however, whether it has any significant effect on survival times. It may also be of benefit in treating the effects associated with valvular heart disease (mitral regurgitation) and left to right shunts. It is being explored as adjunctive treatment in chronic renal failure and protein losing nephropathies.
While ACE inhibitors are a mainstay for treating hypertension in humans, they have not been particularly useful in treating hypertension in dogs or cats.

Drug interactions

Potentially hazardous interactions with other drugs
Anaesthetics: enhanced hypotensive effect.
Analgesics: antagonism of hypotensive effect and increased risk of renal impairment with NSAIDs; hyperkalaemia with ketorolac and other NSAIDs
Antihypertensives: increased risk of hyperkalaemia, hypotension and renal failure with ARBs and aliskiren.
Bee venom extract: possible severe anaphylactoid reactions when used together
Ciclosporin: increased risk of hyperkalaemia and nephrotoxicity.
Cytotoxics: increased risk of angioedema with everolimus.
Diuretics: enhanced hypotensive effect;hyperkalaemia with potassium-sparing diuretics
ESAs: increased risk of hyperkalaemia; antagonism of hypotensive effect.
Gold: flushing and hypotension with sodium aurothiomalate.
Lithium: reduced excretion, possibility of enhanced lithium toxicity.
Potassium salts: increased risk of hyperkalaemia
Tacrolimus: increased risk of hyperkalaemia and nephrotoxicity.

Metabolism

Following absorption, oral enalapril is rapidly and extensively hydrolysed to enalaprilat, a potent angiotensin converting enzyme inhibitor. Peak serum concentrations of enalaprilat occur about 4 hours after an oral dose of enalapril tablet, and the effective half-life is 11 hours. Excretion of enalaprilat is primarily renal. The principal components in urine are enalaprilat, accounting for about 40% of the dose, and intact enalapril.

82717-96-2
76095-16-4
Synthesis of Enalapril maleate from N-[(S)-(+)-1-(Ethoxycarbonyl)-3-phenylpropyl]-L-alanine

Enalapril maleate Preparation Products And Raw materials

Global( 612)Suppliers
Supplier Tel Email Country ProdList Advantage
APOLLO HEALTHCARE RESOURCES
+6596580999 sales@apollo-healthcare.com.sg Singapore 400 58
Hebei Mojin Biotechnology Co., Ltd
+8613288715578 sales@hbmojin.com China 12457 58
Hebei Dangtong Import and export Co LTD
+8615632927689 admin@hbdangtong.com China 991 58
Hangzhou ICH Biofarm Co., Ltd
+undefined8613073685410 sales@ichemie.com China 985 58
Henan Fengda Chemical Co., Ltd
+86-371-86557731 +86-13613820652 info@fdachem.com China 7613 58
Shaanxi TNJONE Pharmaceutical Co., Ltd
+86-13474506593 +86-13474506593 sarah@tnjone.com China 864 58
Henan Tianfu Chemical Co.,Ltd.
+86-0371-55170693 +86-19937530512 info@tianfuchem.com China 21695 55
Hubei XinRunde Chemical Co., Ltd.
+8615102730682 bruce@xrdchem.cn CHINA 566 55
career henan chemical co
+86-0371-86658258 sales@coreychem.com China 29914 58
Zhejiang ZETian Fine Chemicals Co. LTD
18957127338 stella@zetchem.com China 2141 58

View Lastest Price from Enalapril maleate manufacturers

Image Update time Product Price Min. Order Purity Supply Ability Manufacturer
Enalapril maleate pictures 2024-04-24 Enalapril maleate
76095-16-4
US $158.00-100.00 / kg 1kg 99% 1000kg Hebei Dangtong Import and export Co LTD
Enalapril maleate pictures 2024-04-18 Enalapril maleate
76095-16-4
US $35.00-1.20 / kg 1kg 99% g-kg-tons, free sample is available Henan Fengda Chemical Co., Ltd
Enalapril Maleate  pictures 2024-04-10 Enalapril Maleate
76095-16-4
US $0.00-0.00 / mg 10mg 90%+ 10g Guangzhou PI PI BIOTECH INC
  • Enalapril maleate pictures
  • Enalapril maleate
    76095-16-4
  • US $158.00-100.00 / kg
  • 99%
  • Hebei Dangtong Import and export Co LTD

Enalapril maleate Spectrum

1-(n-(1-(ethoxycarbonyl)-3-phenylpropyl)-l-alanyl)-l-prolin(s)-l-prolin(z)-2-bu 1-[n-[1-(ethoxycarbonyl)-3-phenylpropyl]-l-alanyl]-l-prolin(s)-l-prolin(z)-2-but mk421maleate n-((s)-1-ethoxycarbonyl-3-phenylpropyl)-l-alanyl-l-proline maleate ENALAPRIL MALLATE Enalapril Maleate USP24,25,EP2000 Enalapril maleate BP2000/USP25 ENALAPRIL MALEATE, IMP. I (EP): 1H-IMIDAZOLE MM(CRM STANDARD) (s)-1-(n-(1-(ethoxycarbonyl)-3-phenylpropyl)-l-alanyl)-l-prolinemaleate(1:1 Biocronil BQL Controlvas Converten Convertin Ednyt Elfonal Enacard Enaladil Enaloc Enapren Enapril Enaprin Enaril Envas Glioten Hipoartel Hytrol Innovace Innovade Inoprilat Invoril Kenopril Lapril Lotrial L-Proline, 1-[N-[1-(ethoxycarbonyl)-3-phenylpropyl]-L-alanyl]-, (S)-, (Z)-2-butenedioate (1:1) Minipril Naprilene Naritec Nuril Pres Presil Pressotec Renavace Reniten Repantril Sintec Tenace Unaril Vasopril Xanef ENALAPRIL MALEATE, IMP. D (EP): ETHYL(2S)-2-[(3S,8AS)-3-METHYL-1,4-DIOXO-OCTAHYDROPYRROLO[1,2-ALPHA]PYRAZIN-2-YL]-4-PHENYLBUTANOATE MM(CRM STANDARD) ENALAPRIL MALEATE, MM(CRM STANDARD) ENALAPRIL MALEATE, EP STANDARD ENALAPRIL MALEATE, USP STANDARD ENALAPRIL MALEATE EPE ENALAPRIL MALEATE EPE(CRM STANDARD) ENALAPRIL MALEATE MM ENALAPRIL MALEATE USP